Skip to Main Content
Contribute Try STAT+ Today

MENLO PARK, Calif. — The avenue known as Sand Hill Road is lined with low-slung, beige-hued buildings, interspersed with sunny courtyards and flowing fountains. If you didn’t know better, you could easily confuse venture capital’s Main Street for a resort.

Up-and-coming tech CEOs have long been making the pilgrimage here for an all-important 50-minute meeting with Andreessen Horowitz, among the most prestigious of the many VC firms that have set up shop in the area. Now, more and more life sciences entrepreneurs are scoring meetings, too.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • The obvious should be noted: Biotech’s birthplace is the Bay Area, and its size there is still a multiple of that of the Boston Area, which admittingly also has tech. Maybe its more a difference between West and East Coast.

Comments are closed.